Sumatriptan 85 mg, in a rapidly dissolving form, with naproxen sodium 500 mg in a bilayer tablet, was approved as a combination tablet for the acute treatment of migraine by the US FDA on Apr 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback